Lisaftoclax
Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.
Product Specifications
CAS Number
2180923-05-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
882.43
Molecular Formula
C45H48ClN7O8S
Notes
Research use only, not for human use.
Receptor
E3 ligase ligand-linker conjugate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
